BioCentury
ARTICLE | Financial News

Ascendis raises $108M in upsized IPO

January 29, 2015 1:39 AM UTC

Ascendis Pharma A/S (NASDAQ:ASND) gained $0.83 to $18.83 in its first day of trading after raising $108 million in an upsized IPO on NASDAQ through the sale of 6 million American Depositary Shares (ADSs) at $18. The IPO price values Ascendis at $412.8 million. BofA Merrill Lynch; Leerink Partners; and Wells Fargo are underwriters.

Ascendis filed to raise up to $86.3 million in December, and on Monday amended the offering to sell 5 million ADSs at $16-$18. At the midpoint it would have raised $85 million. ...